Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Xenon Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -102.3 M, a 57.27% increase year-over-year.
• Xenon Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -343.0 M, a 66.65% increase year-over-year.
• Xenon Pharmaceuticals Inc. annual net income for 2025 was -345.9 M, a 47.62% increase from 2024.
• Xenon Pharmaceuticals Inc. annual net income for 2024 was -234.3 M, a 28.48% increase from 2023.
• Xenon Pharmaceuticals Inc. annual net income for 2023 was -182.4 M, a 45.48% increase from 2022.
• Xenon Pharmaceuticals Inc. annual net income for 2022 was -125.4 M.